| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0044029 | BP | hypomethylation of CpG island | An decrease in the epigenetic methylation of cytosine and adenosine residues in a CpG island in DNA. CpG islands are genomic regions that contain a high frequency of the CG dinucleotide and are often associated with the transcription start site of genes. |
PIK3CA |
GO:0044030 | BP | regulation of DNA methylation | Any process that modulates the frequency, rate or extent of the covalent transfer of a methyl group to either N-6 of adenine or C-5 or N-4 of cytosine. |
MBD3, PARP1, BRCA1, MPHOSPH8, MIS18A |
GO:0044053 | BP | translocation of peptides or proteins into host cell cytoplasm | The directed movement of peptides or proteins produced by a symbiont organism to a location within the host cell cytoplasm. |
TCP1 |
GO:0044065 | BP | regulation of respiratory system process | Any process that modulates the frequency, rate or extent of a respiratory system process, an organ system process carried out by any of the organs or tissues of the respiratory system. |
MTG1, FTO, MTG2 |
GO:0044070 | BP | regulation of anion transport | Any process that modulates the frequency, rate or extent of the directed movement of anions, atoms or small molecules with a net negative charge into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
AHCYL1, CA2, STC1, RAB11B, LRRC8A, LRRC8C, TTYH1 |
GO:0044088 | BP | regulation of vacuole organization | Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a vacuole. |
MTM1 |
GO:0044089 | BP | positive regulation of cellular component biogenesis | Any process that activates or increases the frequency, rate or extent of cellular component biogenesis, a process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a cellular component. |
LDB2 |
GO:0044090 | BP | positive regulation of vacuole organization | Any process that activates or increases the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a vacuole. |
KIAA1324 |
GO:0044117 | BP | growth of symbiont in host | The increase in size or mass of an organism, occurring within the cells or tissues of the host organism. This may (but not necessarily) include a filamentous growth form, and also can include secretion of proteases and lipases to break down host tissue. The host is defined as the larger of the organisms involved in a symbiotic interaction. |
PGLYRP2 |
GO:0044128 | BP | positive regulation of growth of symbiont in host | Any process in which the symbiont activates, maintains or increases its size or mass within the cells or tissues of the host organism. The host is defined as the larger of the organisms involved in the symbiotic interaction. |
OSBP |
GO:0044130 | BP | negative regulation of growth of symbiont in host | Any process in which the symbiont stops, prevents or reduces its increase in size or mass within the cells or tissues of the host organism. The host is defined as the larger of the organisms involved in the symbiotic interaction. |
TNF, MPO, MBL2, CD36, IL10, TIRAP, SQSTM1 |
GO:0044154 | BP | histone H3-K14 acetylation | The modification of histone H3 by the addition of an acetyl group to a lysine residue at position 14 of the histone. |
MEAF6 |
GO:0044183 | MF | protein binding involved in protein folding | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules) that contributes to the process of protein folding. |
CLGN, CD74, HSPA1A, HSPA1B, CALR, CCT6A, CCT3, CCT2, PDCL3 |
GO:0044194 | CC | cytolytic granule | A specialized secretory lysosome that is present in cells with cytolytic capability such as cytotoxic T lymphocytes and natural killer cells. Cytolytic granules mediate the storage and regulated excretion of lytic molecules for killing of target cells. |
LAMP1, STXBP2, RNF19B |
GO:0044205 | BP | de novo' UMP biosynthetic process | The chemical reactions and pathways resulting in the formation of UMP, uridine monophosphate, starting with the synthesis of (S)-dihydroorotate from bicarbonate; UMP biosynthesis may either occur via reduction by quinone, NAD(+) or oxygen. |
UMPS, CAD, DHODH |
GO:0044206 | BP | UMP salvage | Any process which produces UMP, uridine monophosphate, from derivatives of it (e.g. cytidine, uridine, cytosine) without de novo synthesis. |
UPP2, UPP1, UCK2, UCK1, UCKL1 |
GO:0044207 | CC | translation initiation ternary complex | A ribonucleoprotein complex that contains aminoacylated initiator methionine tRNA, GTP, and initiation factor 2 (either eIF2 in eukaryotes, or IF2 in prokaryotes). In prokaryotes, fMet-tRNA (initiator) is used rather than Met-tRNA (initiator). |
EIF2S1 |
GO:0044208 | BP | de novo' AMP biosynthetic process | The chemical reactions and pathways resulting in the formation of adenosine monophosphate (AMP) from inosine 5'-monophosphate (IMP). |
ADSS, ADSL, ADSSL1 |
GO:0044209 | BP | AMP salvage | The chemical reactions and pathways resulting in the formation of adenosine monophosphate (AMP) from derivatives of it (either adenine, ADP or adenosine 3',5'-bisphosphate) without de novo synthesis. |
APRT |
GO:0044210 | BP | de novo' CTP biosynthetic process | The chemical reactions and pathways resulting in the formation of cytidine 5'-triphosphate (CTP) from simpler components. |
CTPS1, CTPS2 |
GO:0044211 | BP | CTP salvage | Any process which produces cytidine 5'-triphosphate (CTP) from derivatives of it, without de novo synthesis. |
UCK2, UCK1, UCKL1 |
GO:0044212 | MF | transcription regulatory region DNA binding | Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors. |
NR5A2, SMAD7, KLF4, SMAD6, KDM1A, CCNT1, TBL1X, ZNF217, H2AFY, NCOR1, FOS, TNF, TP53, JUN, AR, THRA, EGR2, XRCC5, HNRNPL, HIVEP1, JUND, TAL1, ATF3, ATF4, TFEB, WT1, NFKB1, NR1D1, HNF1A, SFPQ, NFYB, YY1, HMGB2, MZF1, HIVEP2, CTNNB1, PHB, DDIT3, SOX6, AHR, PPARG, SNCA, BRCA1, STAT3, ETV5, WNT5A, GATA4, NKX2-1, YAP1, SMARCA2, DLX5, HDAC4, SMAD3, ZNF200, HHEX, RELA, MEF2C, GABPA, PAX8, FOXC1, NR1H3, IKZF1, SMAD4, HDAC1, NFYC, ARID5B, RBBP5, ERBB4, TAF5, ARID4B, HIVEP3, CARM1, ZNF567, ZNF513, CTCFL, GABPB2, ZNF564, GLMP, PROX1, GATA6, CREB3L1, ZNF382, TCF12, CDC5L, CITED1, SALL3, TBL1XR1, IKZF4, DHX36, ZNF335, SOX17, TAF9B, ZNF532, TCF7L1, BRD7, TCF7L2, GRHL1, H2AFY2, RCOR3, ASH2L, TCF20, ZNF639, KLF15, HDAC5 |
GO:0044213 | MF | intronic transcription regulatory region DNA binding | Interacting selectively and non-covalently with an intronic DNA region that regulates the transcription of the transcript it is contained within. |
NKX2-1 |
GO:0044214 | CC | spanning component of plasma membrane | The component of the plasma membrane consisting of gene products and protein complexes that have some part that spans both leaflets of the membrane. |
BMPR2, CDHR2 |
GO:0044216 | CC | other organism cell | A cell of a secondary organism with which the first organism is interacting. |
C4A, C4B |
GO:0044224 | CC | juxtaparanode region of axon | A region of an axon near a node of Ranvier that is between the paranode and internode regions. |
DLG4, KCNA1, SIRT2, EPB41L3 |
GO:0044232 | CC | organelle membrane contact site | A zone of apposition between the membranes of two organelles, structured by bridging complexes. Membrane contact sites (MCSs) are specialized for communication, including the efficient traffic of small molecules such as Ca2+ ions and lipids, as well as enzyme-substrate interactions. |
ESYT2, ESYT1 |
GO:0044233 | CC | ER-mitochondrion membrane contact site | A zone of apposition between endoplasmic-reticulum and mitochondrial membranes, structured by bridging complexes. These contact sites are thought to facilitate inter-organelle calcium and phospholipid exchange. |
ACSL4, CANX, RAB32, TOMM20, ZFYVE1 |
GO:0044236 | BP | multicellular organism metabolic process | The chemical reactions and pathways in a single multicellular organism that occur at the tissue, organ, or organismal level. These processes, unlike cellular metabolism, can include transport of substances between cells when that transport is required. |
GHR |
GO:0044241 | BP | lipid digestion | The whole of the physical, chemical, and biochemical processes carried out by living organisms to break down ingested lipids into components that may be easily absorbed and directed into metabolism. |
LIPH, LMF1, LIPG |
GO:0044242 | BP | cellular lipid catabolic process | The chemical reactions and pathways resulting in the breakdown of lipids, as carried out by individual cells. |
MT3, SIRT2 |
GO:0044245 | BP | polysaccharide digestion | The whole of the physical, chemical, and biochemical processes carried out by living organisms to break down ingested polysaccharides into components that may be easily absorbed and directed into metabolism. |
MGAM, LCT |
GO:0044252 | BP | negative regulation of multicellular organismal metabolic process | Any process that stops, prevents or reduces frequency, rate or extent of chemical reactions and pathways in multicellular organisms that occur at the tissue, organ, or organismal level. |
ARRDC3 |
GO:0044255 | BP | cellular lipid metabolic process | The chemical reactions and pathways involving lipids, as carried out by individual cells. |
HDAC3, TBL1X, SIN3B, NCOR1, ECI2, NUDT7, GPD2, NR1H2, PPARA, NCOA2, NCOA1, CHD9, SMARCD3, PNPLA5, CARM1, CREBBP, HELZ2, TBL1XR1, HAO2, FAM135A, NCOR2 |
GO:0044257 | BP | cellular protein catabolic process | The chemical reactions and pathways resulting in the breakdown of a protein by individual cells. |
DENND3, SIAH2, PARK2, APOB, PPT1, RIPK1, RAB12 |
GO:0044259 | BP | multicellular organismal macromolecule metabolic process | The chemical reactions and pathways involving macromolecules, large molecules including proteins, nucleic acids and carbohydrates, in multicellular organisms occurring at the tissue, organ, or organismal level. |
AKR1C3 |
GO:0044262 | BP | cellular carbohydrate metabolic process | The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells. |
TKFC, IDNK |
GO:0044265 | BP | cellular macromolecule catabolic process | The chemical reactions and pathways resulting in the breakdown of a macromolecule, any large molecule including proteins, nucleic acids and carbohydrates, as carried out by individual cells. |
CLN6 |
GO:0044267 | BP | cellular protein metabolic process | The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
SIAH2, PARK2, F2, PLG, CST3, PRL, INS, IGF2, APOA1, FGA, APCS, TTR, MMP1, IGF1, APP, KLK3, MMP2, IGFBP1, CTSH, FURIN, UBC, SAA1, IAPP, SFTPC, IGFBP3, IGFBP2, IGFBP4, IGFBP6, IGFBP5, ADORA2B, SNCA, LYZ, B2M, HIST1H4A, RPS27A, UBA52, HIST1H3D, H3F3A, HSPG2, MFGE8, PAPPA, TGFBI, GIGYF2, SIAH1, GATA6, LMCD1, CCDC59, DMBT1, ZDHHC2, GGA2, GGA1, ITM2B, SNCAIP |
GO:0044275 | BP | cellular carbohydrate catabolic process | The chemical reactions and pathways resulting in the breakdown of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells. |
ENOSF1 |
GO:0044281 | BP | small molecule metabolic process | The chemical reactions and pathways involving small molecules, any low molecular weight, monomeric, non-encoded molecule. |
FDX1, FXN, FDX1L |
GO:0044291 | CC | cell-cell contact zone | Extended zone of intimate apposition between two cells containing one or more types of intercellular junctions, e.g., the intercalated disk of muscle. |
FLOT1, RAP2B, AHNAK, TIAM1, FLCN, PKP4, JAM3, PCDH9 |
GO:0044294 | CC | dendritic growth cone | The migrating motile tip of a growing nerve cell dendrite. |
COBL, PTCH1, MAPK8IP1 |
GO:0044295 | CC | axonal growth cone | The migrating motile tip of a growing nerve cell axon. |
COBL, EPHA4, FKBP4, TIAM1, PTCH1, PARD3, OLFM1, FLRT3, MAPK8IP1, TRPV2 |
GO:0044297 | CC | cell body | The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections. |
TLR2, STAU1, GNAI2, TUBB, MAPT, EZR, GNB3, TCP1, COMT, NF2, RPL28, CCT3, GNAQ, CCT8, ACTA2, RPS6, GNB1, GNB2, ACTG2, ACTC1, CXADR, CCT2, NRG1, FADD, DPYSL3, CASP8, RDH10, PACRG, CCT7, SYT11, PINK1, GABARAPL1, CACYBP, MAPK8IP1, LZTS1, TRPV2 |
GO:0044299 | CC | C-fiber | The axon of a dorsal root ganglion cell that are responsive to pain and temperature. C-fibers are small in diameter (0.2-1.5 um) and unmyelinated. |
CCL2 |
GO:0044300 | CC | cerebellar mossy fiber | An axon arising from cerebellar projecting cells in the cochlea, vestibular nuclei, spinal cord, reticular formation, cerebellar nuclei and basilar pontine nuclei. Mossy fibers enter through all three cerebellar peduncles and send collaterals to the deep cerebellar nuclei, then branch in the white matter and terminate in the granule cell layer. Through this branching, a given mossy fiber can innervate several folia. Mossy fibers synapse on granule cells. The synaptic contacts are made at enlargements along the length of the mossy fiber called mossy fiber rosettes. The enlargements of the rosettes give the axons as mossy appearance in Golgi stained preparations. |
NFIB, DLG4 |
GO:0044302 | CC | dentate gyrus mossy fiber | Distinctive, unmyelinated axons produced by granule cells. |
MAPK8IP1 |
GO:0044304 | CC | main axon | The main axonal trunk, as opposed to the collaterals; i.e., excluding collaterals, terminal, spines, or dendrites. |
APBB1, APP, TIAM1 |
GO:0044306 | CC | neuron projection terminus | The specialized, terminal region of a neuron projection such as an axon or a dendrite. |
SCRG1, MME, UCHL1, DMD, VAMP2, DLG4, TMEM57, FLRT1 |
GO:0044308 | CC | axonal spine | A spine that originates from the axon, usually from the initial segment. |
EEA1, SLC9A6 |
GO:0044309 | CC | neuron spine | A small membranous protrusion, often ending in a bulbous head and attached to the neuron by a narrow stalk or neck. |
DLG4 |
GO:0044314 | BP | protein K27-linked ubiquitination | A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 27 of the ubiquitin monomers, is added to a protein. |
PARK2, UBE2S, UBE2T, RNF6, UBE2D4 |
GO:0044319 | BP | wound healing, spreading of cells | The migration of a cell along or through a wound gap that contributes to the reestablishment of a continuous surface. |
CYR61, TOR1A, FLNA, RHOA, DDR1, PDCD10, TMEFF2 |
GO:0044320 | BP | cellular response to leptin stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism. |
FGB, INHBB, CCNA2, STAT3, LEP, PID1, NR4A3 |
GO:0044321 | BP | response to leptin | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism]. |
EDN1, NR1D1, STAT3, LEPR, STAR |
GO:0044322 | CC | endoplasmic reticulum quality control compartment | A subcompartment of the endoplasmic reticulum in which proteins with improper or incorrect folding accumulate. Enzymes in this compartment direct proteins with major folding problems to translocation to the cytosol and degradation, and proteins with minor folding problems to the ER, to interact with chaperon proteins. |
OS9, SYVN1, RHBDD1, EDEM1, EDEM3, DERL2, UGGT1, SEL1L, MAN1B1 |
GO:0044323 | MF | retinoic acid-responsive element binding | Interacting selectively and non-covalently with a retinoic acid-responsive element, a variable direct repeat of the sequence PuGGTCA spaced by five nucleotides (DR5) found in the promoters of retinoic acid-responsive genes, to which retinoic acid receptors bind. |
NR2F1 |
GO:0044324 | BP | regulation of transcription involved in anterior/posterior axis specification | Any process that modulates the frequency, rate or extent of transcription that contributes to the specification of the anterior/posterior axis. |
DDIT3 |
GO:0044325 | MF | ion channel binding | Interacting selectively and non-covalently with one or more specific sites on an ion channel, a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient. |
FXYD1, ACTN4, PRNP, FYN, HSP90AA1, LYN, HSP90AB1, TRAPPC2, ACTN1, PRKCSH, TSPO, SRI, CDH5, CTNNB1, ACTN2, HTT, S100A10, FGF12, CALM2, YWHAE, PKD1, ANK2, ID2, CAV1, YWHAH, FMR1, PDE4D, ANK3, DLG1, AKAP6, SNTA1, CAMK2D, PKD2, FHL1, KCNJ11, GRINA, HOMER1, CHERP, KCNE4, RYR2, FGF13, AP2M1, NEDD4L, PANX1, CIB1, PKP2, RIMS4, GOPC, RANGRF, PHPT1, KCNIP2, PYCARD, RIMS2, TCAF1 |
GO:0044326 | CC | dendritic spine neck | Part of the dendritic spine that connects the dendritic shaft to the head of the dendritic spine. |
SRI |
GO:0044327 | CC | dendritic spine head | Distal part of the dendritic spine, that carries the post-synaptic density. |
FUS, GPER1 |
GO:0044328 | BP | canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in the positive regulation of endothelial cell migration. |
PLPP3 |
GO:0044329 | BP | canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in the positive regulation of cell to cell adhesion. |
PLPP3 |
GO:0044330 | BP | canonical Wnt signaling pathway involved in positive regulation of wound healing | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in positive regulation of wound healing. |
PLPP3 |
GO:0044331 | BP | cell-cell adhesion mediated by cadherin | The attachment of one cell to another cell via a cadherin, transmembrane proteins having repeating extracellular calcium ion binding domains. |
CDH2, CDHR2, MMP24 |
GO:0044332 | BP | Wnt signaling pathway involved in dorsal/ventral axis specification | The series of molecular signals initiated by binding of Wnt protein to a frizzled family receptor on the surface of the target cell contributing to the establishment, maintenance and elaboration of the dorsal/ventral axis. |
LRP5, LRP6 |
GO:0044334 | BP | canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in the positive regulation of epithelial cell to mesenchymal cell transition. |
CTNNB1, TCF7L2 |
GO:0044335 | BP | canonical Wnt signaling pathway involved in neural crest cell differentiation | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in neural crest cell differentiation. |
LRP6 |
GO:0044336 | BP | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in the negative regulation of apoptotic process. |
CTNNB1 |
GO:0044337 | BP | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in the positive regulation of apoptotic process. |
GSK3B |
GO:0044338 | BP | canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in mesenchymal stem cell differentiation. |
WNT3 |
GO:0044339 | BP | canonical Wnt signaling pathway involved in osteoblast differentiation | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in osteoblast differentiation. |
WNT3 |
GO:0044340 | BP | canonical Wnt signaling pathway involved in regulation of cell proliferation | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes that contributes to modulating the rate or frequency of cell proliferation. |
LRP6 |
GO:0044341 | BP | sodium-dependent phosphate transport | The directed movement of phosphate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore, by a mechanism dependent upon sodium ions. |
SLC20A2, SLC20A1 |
GO:0044342 | BP | type B pancreatic cell proliferation | The multiplication or reproduction of pancreatic B cells, resulting in the expansion of an pancreatic B cell population. Pancreatic B cell are cells of the pancreas that secrete insulin. |
IGFBP3, IGFBP4, IGFBP5, BAD |
GO:0044344 | BP | cellular response to fibroblast growth factor stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an fibroblast growth factor stimulus. |
ITGB1BP1, TBX1, SNAI2, COL1A1, CXCL8, TDGF1, CCL2, CCL5, CD44, NR4A1, ZFP36, SNCA, ZFP36L2, GCLC, GCLM, STAR, EGR3, ZFP36L1, HYAL2, POSTN, DSTYK, SETX, SFRP1, CDC5L, DLL4, KDM5B |
GO:0044345 | BP | stromal-epithelial cell signaling involved in prostate gland development | The process of transferring information from a stromal cell to an epithelial cell where it is received and interpreted, as part of prostate gland development. |
SFRP1 |
GO:0044346 | BP | fibroblast apoptotic process | Any apoptotic process in a fibroblast, a connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. |
MYC, CUL3 |
GO:0044351 | BP | macropinocytosis | An endocytosis process that results in the uptake of liquid material by cells from their external environment by the 'ruffling' of the cell membrane to form heterogeneously sized intracellular vesicles called macropinosomes, which can be up to 5 micrometers in size. |
MAPKAPK2, LRRC16A, SNX33, DOCK2, PYCARD |
GO:0044354 | CC | macropinosome | A membrane-bounded, uncoated intracellular vesicle formed by the process of macropinocytosis. |
ANXA2, CLIP1, MMP14, LRRC16A, ANKFY1 |
GO:0044375 | BP | regulation of peroxisome size | Any process that modulates the volume of a peroxisome, a small, membrane-bounded organelle that uses dioxygen (O2) to oxidize organic molecules. |
PEX11B |
GO:0044377 | MF | RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending | Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence. |
CEBPG |
GO:0044378 | MF | non-sequence-specific DNA binding, bending | The activity of binding selectively and non-covalently to DNA in a sequence-independent manner and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence. |
HMGB2 |
GO:0044380 | BP | protein localization to cytoskeleton | A process in which a protein is transported to, or maintained in, a location within the cytoskeleton. |
FAM83H |
GO:0044387 | BP | negative regulation of protein kinase activity by regulation of protein phosphorylation | The stopping, prevention, or reduction in frequency, rate or extent of protein kinase activity as a result of regulating the phosphorylation status of that protein kinase. |
NPM1, PPM1F, ADARB1, DUSP26, CORO1C, DUSP10 |
GO:0044389 | MF | ubiquitin-like protein ligase binding | Interacting selectively and non-covalently with a ubiquitin-like protein ligase, such as ubiquitin-ligase. |
CEBPB, XBP1, VCP, USP13 |
GO:0044393 | CC | microspike | A dynamic, actin-rich projection extending from the surface of a migrating animal cell. |
EZR, FSCN1 |
GO:0044406 | BP | adhesion of symbiont to host | The attachment of a symbiont to its host via adhesion molecules, general stickiness etc., either directly or indirectly. The host is defined as the larger of the organisms involved in a symbiotic interaction. |
ICAM1, SCARB1 |
GO:0044458 | BP | motile cilium assembly | The assembly of a motile cilium, a cilium that contains a regular longitudinal array of axonemal microtubules. In vertebrates, motile cilia are usually formed around a 9 + 2 microtubule core structure. Motile cilia are often found in tissues where propagation of fluid is necessary for proper organ development or function. |
BBOF1, CC2D2A |
GO:0044524 | BP | protein sulfhydration | The modification of a protein amino acid by the addition of sulfur. |
CTH |
GO:0044530 | CC | supraspliceosomal complex | Multicomponent complex of RNA and proteins that is composed of four active spliceosomes, termed native spliceosomes, connected to each other by the pre-mRNA. The supraspliceosome is the nuclear machine where the pre-mRNA processing takes place, like the 5'-end capping, 3'-end cleavage, splicing and editing. |
RBMX |
GO:0044539 | BP | long-chain fatty acid import | The directed movement of long-chain fatty acids into a cell or organelle. A long-chain fatty acid is a fatty acid with a chain length between C13 and C22. |
SLC27A2, FABP3, CD36, ACSL1, SLC27A4, SPX |
GO:0044540 | MF | L-cystine L-cysteine-lyase (deaminating) | Catalysis of the reaction: L-cystine + H2O <=> pyruvate + NH3 + thiocysteine. Thiocysteine is also known as cysteine persulfide. |
CTH |
GO:0044548 | MF | S100 protein binding | Interacting selectively and non-covalently with a S100 protein. S100 is a small calcium and zinc binding protein produced in astrocytes that is implicated in Alzheimer's disease, Down Syndrome and ALS. |
KCNK3, S100B, S100A6, ANXA2, EZR, ATP2A2, S100A11, IQGAP1, ANXA11, AHNAK |
GO:0044550 | BP | secondary metabolite biosynthetic process | The chemical reactions and pathways resulting in the formation of secondary metabolites, the compounds that are not necessarily required for growth and maintenance of cells, and are often unique to a taxon. |
KMO, CYP11A1, CYP11B1, CYP11B2 |
GO:0044565 | BP | dendritic cell proliferation | The expansion of a dendritic cell population by cell division. A dendritic cell is a cell of hematopoietic origin, typically resident in particular tissues, specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. |
AZI2, TBK1 |
GO:0044594 | MF | 17-beta-hydroxysteroid dehydrogenase (NAD+) activity | Catalysis of the reaction: a 17-beta-hydroxysteroid + NAD+ = a 17-oxosteroid + NADH + H+. |
HSD17B4 |
GO:0044595 | MF | decaprenyldihydroxybenzoate methyltransferase activity | Catalysis of the reaction: S-adenosyl-L-methionine + 3-decaprenyl-4,5-dihydroxybenzoate = S-adenosyl-L-homocysteine + 3-decaprenyl-4-hydroxy-5-methoxybenzoate. |
COQ3 |
GO:0044596 | MF | 3-demethylubiquinone-10 3-O-methyltransferase activity | Catalysis of the reaction: S-adenosyl-L-methionine + 3-demethylubiquinone-10 = S-adenosyl-L-homocysteine + ubiquinone-10. |
COQ3 |